Swedish Orphan Biovitrum cash flow from operating activities for the twelve months ending September 30, 2024 was $1.603B, a 34.91% increase year-over-year.
Swedish Orphan Biovitrum annual cash flow from operating activities for 2023 was $0.422B, a 8.82% decline from 2022.
Swedish Orphan Biovitrum annual cash flow from operating activities for 2022 was $0.462B, a 27.52% decline from 2021.
Swedish Orphan Biovitrum annual cash flow from operating activities for 2021 was $0.638B, a 12.22% increase from 2020.
Swedish Orphan Biovitrum Cash Flow from Operating Activities 2019-2024 | BIOVF